93 related articles for article (PubMed ID: 22588875)
1. Circulating endothelial progenitors and tumor resistance to vascular-targeting therapies.
De Palma M; Nucera S
Cancer Discov; 2012 May; 2(5):395-7. PubMed ID: 22588875
[TBL] [Abstract][Full Text] [Related]
2. Reversing resistance to vascular-disrupting agents by blocking late mobilization of circulating endothelial progenitor cells.
Taylor M; Billiot F; Marty V; Rouffiac V; Cohen P; Tournay E; Opolon P; Louache F; Vassal G; Laplace-Builhé C; Vielh P; Soria JC; Farace F
Cancer Discov; 2012 May; 2(5):434-49. PubMed ID: 22588881
[TBL] [Abstract][Full Text] [Related]
3. Redefining the target again: chemotherapeutics as vascular disrupting agents?
Gokmen-Polar Y; Miller KD
Cancer Cell; 2008 Sep; 14(3):195-6. PubMed ID: 18772108
[TBL] [Abstract][Full Text] [Related]
4. Vascular disrupting therapy-induced mobilization of circulating endothelial progenitor cells.
Farace F; Massard C; Borghi E; Bidart JM; Soria JC
Ann Oncol; 2007 Aug; 18(8):1421-2. PubMed ID: 17693656
[No Abstract] [Full Text] [Related]
5. Decursin inhibits vasculogenesis in early tumor progression by suppression of endothelial progenitor cell differentiation and function.
Jung SY; Choi JH; Kwon SM; Masuda H; Asahara T; Lee YM
J Cell Biochem; 2012 May; 113(5):1478-87. PubMed ID: 22298358
[TBL] [Abstract][Full Text] [Related]
6. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
[TBL] [Abstract][Full Text] [Related]
7. Targeting inflammatory cells to improve anti-VEGF therapies in oncology.
Gerber HP; Olazoglu E; Grewal IS
Recent Results Cancer Res; 2010; 180():185-200. PubMed ID: 20033384
[TBL] [Abstract][Full Text] [Related]
8. Circulating endothelial cells as biomarkers in clinical oncology.
Mancuso P; Bertolini F
Microvasc Res; 2010 May; 79(3):224-8. PubMed ID: 20176038
[TBL] [Abstract][Full Text] [Related]
9. Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting.
Santini D; Zoccoli A; Gregorj C; Di Cerbo M; Iuliani M; Pantano F; Zamarchi R; Sergi F; Flammia G; Buscarini M; Rizzo S; Cicero G; Russo A; Vincenzi B; Avvisati G; Tonini G
Oncology; 2013; 85(6):342-7. PubMed ID: 24335337
[TBL] [Abstract][Full Text] [Related]
10. Myoseverin is a potential angiogenesis inhibitor by inhibiting endothelial cell function and endothelial progenitor cell differentiation.
Park HE; Baek SH; Min J; Chang YT; Kang DK; Chang SI; Joe YA
DNA Cell Biol; 2006 Sep; 25(9):514-22. PubMed ID: 16989574
[TBL] [Abstract][Full Text] [Related]
11. Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis.
Shaked Y; Bertolini F; Man S; Rogers MS; Cervi D; Foutz T; Rawn K; Voskas D; Dumont DJ; Ben-David Y; Lawler J; Henkin J; Huber J; Hicklin DJ; D'Amato RJ; Kerbel RS
Cancer Cell; 2005 Jan; 7(1):101-11. PubMed ID: 15652753
[TBL] [Abstract][Full Text] [Related]
12. Propranolol inhibits endothelial progenitor cell homing: a possible treatment mechanism of infantile hemangioma.
Zou HX; Jia J; Zhang WF; Sun ZJ; Zhao YF
Cardiovasc Pathol; 2013; 22(3):203-10. PubMed ID: 23151525
[TBL] [Abstract][Full Text] [Related]
13. Stem cell-like human endothelial progenitors show enhanced colony-forming capacity after brief sevoflurane exposure: preconditioning of angiogenic cells by volatile anesthetics.
Lucchinetti E; Zeisberger SM; Baruscotti I; Wacker J; Feng J; Zaugg K; Dubey R; Zisch AH; Zaugg M
Anesth Analg; 2009 Oct; 109(4):1117-26. PubMed ID: 19762739
[TBL] [Abstract][Full Text] [Related]
14. Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors.
Shaked Y; Ciarrocchi A; Franco M; Lee CR; Man S; Cheung AM; Hicklin DJ; Chaplin D; Foster FS; Benezra R; Kerbel RS
Science; 2006 Sep; 313(5794):1785-7. PubMed ID: 16990548
[TBL] [Abstract][Full Text] [Related]
15. Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors.
Deschaseaux F; Selmani Z; Falcoz PE; Mersin N; Meneveau N; Penfornis A; Kleinclauss C; Chocron S; Etievent JP; Tiberghien P; Kantelip JP; Davani S
Eur J Pharmacol; 2007 May; 562(1-2):111-8. PubMed ID: 17320859
[TBL] [Abstract][Full Text] [Related]
16. Statins and the endothelium.
Ii M; Losordo DW
Vascul Pharmacol; 2007 Jan; 46(1):1-9. PubMed ID: 16920035
[TBL] [Abstract][Full Text] [Related]
17. Statins and inflammation: reciprocal effectors to endothelial progenitors?
Shantsila E; Watson T; Lip GY
Thromb Res; 2008; 123(1):1-4. PubMed ID: 18485454
[No Abstract] [Full Text] [Related]
18. Circulating endothelial cells as a therapeutic marker for thalidomide in combined therapy with chemotherapy drugs in a human prostate cancer model.
Li H; Raia V; Bertolini F; Price DK; Figg WD
BJU Int; 2008 Apr; 101(7):884-8. PubMed ID: 18070197
[TBL] [Abstract][Full Text] [Related]
19. Plumbagin restrains hepatocellular carcinoma angiogenesis by suppressing the migration and invasion of tumor-derived vascular endothelial cells.
Wei Y; Yang Q; Zhang Y; Zhao T; Liu X; Zhong J; Ma J; Chen Y; Zhao C; Li J
Oncotarget; 2017 Feb; 8(9):15230-15241. PubMed ID: 28122355
[TBL] [Abstract][Full Text] [Related]
20. Insulin modulates ischemia-induced endothelial progenitor cell mobilization and neovascularization in diabetic mice.
Dong L; Kang L; Ding L; Chen Q; Bai J; Gu R; Li L; Xu B
Microvasc Res; 2011 Nov; 82(3):227-36. PubMed ID: 21964072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
